Low-priced, exit-prevention medicines to be waivered from obligatory small package system in August
Published: 2008-07-11 06:59:00
Updated: 2008-07-11 06:59:00
The Korea Food and Drug Administration plans to revamp the controversial small package system, to this effect that low-priced drugs of less than 50 won in price tag and/or exit-prevention medicines should be excluded from the current small drug package obligation from next month.
The KFDA said...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
